If you are looking to get a weight loss drug but lack insurance coverage, telehealth websites such as Ro, Hers and Mochi Health sell GLP-1 drugs for lower prices than what you’d pay at a pharmacy, ...

President Donald J. Trump recently announced a new prescription drug policy. It turns out the United States has been ripped ...

Novo Nordisk (NYSE: NVO) and Cava Group (NYSE: CAVA) are excellent choices. Novo Nordisk's shares have significantly lagged ...

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant ...

We came across a bullish thesis on The Cigna Group (CI) on Antonio Linares’ Substack. In this article, we will summarize the ...

The study, the first head-to-head comparison of the two, was funded by Lilly. Novo Nordisk's share price is down 54% from its peak in June 2024. Its U.S.-listed shares fell another 3% in morning ...

Novo Nordisk continues to deliver strong revenue, profit growth, and high economic profitability. Read why I rate NVO stock a ...

Macy’s beat earnings estimates for the fourth quarter, but cut its 2025 profit outlook as tariffs complicate its turnaround strategy.

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

The new locations, dubbed J.P. Morgan Financial Centers, have a feel and earth-tone color palette that sets them apart from ...

Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...

PolyPeptide Group, the Swiss drug ingredients manufacturer, has exercised an option to increase its revolving credit facility ...